Grotsky et al. suggest that vitamin D prevents the degradation of tumor protein p53-binding protein 1 (TP53BP1) in cancers mediated by a BRCA1 mutation, therefore increasing plasma vitamin D levels and inhibiting cell proliferation in BRCA1 mutation carriers [10]. This evidence concerns the gene BRCA1 and cancer.